$SMG
SCOTTS MIRACLE-GRO CO Stock $smg

$smg Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000154638018000005 Filed on February 08, 2018

Income Statement

Concept	2017 Q4	2016 Q4
Revenue	$221.5M	$207.4M
YoY Change	6.8%
Cost Of Revenue	$187.5M	$170.6M
YoY Change	9.91%
Gross Profit	$34.00M	$36.80M
YoY Change	-7.61%
Gross Profit Margin	15.35%	17.74%
Selling, General & Admin	$108.2M	$104.1M
YoY Change	3.94%
% of Gross Profit	318.24%	282.88%
Research & Development	$9.400M	$8.900M
YoY Change	5.62%
% of Gross Profit	27.65%	24.18%
Depreciation & Amortization	$12.70M	$14.00M
YoY Change	-9.29%
% of Gross Profit	37.35%	38.04%
Operating Expenses	$108.2M	$104.1M
YoY Change	3.94%
Operating Profit	-$71.90M	-$61.80M
YoY Change	16.34%
Interest Expense	$17.80M	$15.30M
YoY Change	16.34%
% of Operating Profit
Other Income/Expense, Net	$2.500M	$0.00
YoY Change
Pretax Income	-$86.60M	-$90.30M
YoY Change	-4.1%
Income Tax	-$66.60M	-$32.20M
% Of Pretax Income
Net Earnings	-$21.20M	-$65.30M
YoY Change	-67.53%
Net Earnings / Revenue	-9.57%	-31.49%
Basic Earnings Per Share	-$0.37	-$1.09
Diluted Earnings Per Share	-$0.37	-$1.09
COMMON SHARES
Basic Shares Outstanding	57.60M shares	60.10M shares
Diluted Shares Outstanding	57.60M shares	60.10M shares

Balance Sheet

Concept	2017 Q4	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$54.50M	$73.10M
YoY Change	-25.44%
Cash & Equivalents	$54.50M	$73.10M
Short-Term Investments
Other Short-Term Assets	$61.70M	$306.5M
YoY Change	-79.87%
Inventory	$696.1M	$685.9M
Prepaid Expenses
Receivables	$128.4M	$175.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$982.9M	$1.241B
YoY Change	-20.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$464.1M	$438.0M
YoY Change	5.96%
Goodwill	$464.8M	$397.4M
YoY Change	16.96%
Intangibles	$783.4M	$734.0M
YoY Change	6.73%
Long-Term Investments	$31.70M	$83.90M
YoY Change	-62.22%
Other Assets	$183.9M	$117.7M
YoY Change	56.24%
Total Long-Term Assets	$1.928B	$1.771B
YoY Change	8.86%
TOTAL ASSETS
Total Short-Term Assets	$982.9M	$1.241B
Total Long-Term Assets	$1.928B	$1.771B
Total Assets	$2.911B	$3.012B
YoY Change	-3.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$223.2M	$218.4M
YoY Change	2.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$86.10M	$41.80M
YoY Change	105.98%
Total Short-Term Liabilities	$471.1M	$490.6M
YoY Change	-3.97%
LONG-TERM LIABILITIES
Long-Term Debt	$1.697B	$1.648B
YoY Change	2.97%
Other Long-Term Liabilities	$213.0M	$281.3M
YoY Change	-24.28%
Total Long-Term Liabilities	$1.910B	$1.929B
YoY Change	-1.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$471.1M	$490.6M
Total Long-Term Liabilities	$1.910B	$1.929B
Total Liabilities	$2.403B	$2.420B
YoY Change	-0.7%
SHAREHOLDERS EQUITY
Retained Earnings	$925.9M	$786.4M
YoY Change	17.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$762.8M	$491.9M
YoY Change	55.07%
Treasury Stock Shares	10.90M shares	8.300M shares
Shareholders Equity	$502.8M	$579.8M
YoY Change
Total Liabilities & Shareholders Equity	$2.911B	$3.012B
YoY Change	-3.37%

Cashflow Statement

Concept	2017 Q4	2016 Q4
OPERATING ACTIVITIES
Net Income	-$21.20M	-$65.30M
YoY Change	-67.53%
Depreciation, Depletion And Amortization	$12.70M	$14.00M
YoY Change	-9.29%
Cash From Operating Activities	-$210.5M	-$209.8M
YoY Change	0.33%
INVESTING ACTIVITIES
Capital Expenditures	$19.40M	$16.10M
YoY Change	20.5%
Acquisitions	$70.00M	$77.90M
YoY Change	-10.14%
Other Investing Activities	$0.00	-$77.90M
YoY Change	-100.0%
Cash From Investing Activities	-$94.70M	-$94.00M
YoY Change	0.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$96.20M	$43.60M
YoY Change	120.64%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$238.6M	$345.2M
YoY Change	-30.88%
NET CHANGE
Cash From Operating Activities	-$210.5M	-$209.8M
Cash From Investing Activities	-$94.70M	-$94.00M
Cash From Financing Activities	$238.6M	$345.2M
Net Change In Cash	-$66.60M	$41.40M
YoY Change	-260.87%
FREE CASH FLOW
Cash From Operating Activities	-$210.5M	-$209.8M
Capital Expenditures	$19.40M	$16.10M
Free Cash Flow	-$229.9M	-$225.9M
YoY Change	1.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	dei	Amendment Flag AmendmentFlag	false
CY2017Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2017Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2017Q4	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017Q4	dei	Document Type DocumentType	10-Q
CY2017Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000825542
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56924442	shares
CY2017Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q4	dei	Entity Registrant Name EntityRegistrantName	SCOTTS MIRACLE-GRO CO
CY2017Q4	dei	Trading Symbol TradingSymbol	SMG
CY2016Q3	smg	Additional Shares Authorized For Repurchase Value AdditionalSharesAuthorizedForRepurchaseValue	500000000	USD
CY2016Q4	smg	Adjustment To Gain On Contribution Of Business AdjustmentToGainOnContributionOfBusiness	300000	USD
CY2017Q4	smg	Adjustment To Gain On Contribution Of Business AdjustmentToGainOnContributionOfBusiness	200000	USD
CY2016Q4	smg	Disposal Group Including Discontinued Operation Debt Noncurrent DisposalGroupIncludingDiscontinuedOperationDebtNoncurrent	29100000	USD
CY2016Q4	smg	Disposal Group Including Discontinued Operation Goodwilland Intangible Assets DisposalGroupIncludingDiscontinuedOperationGoodwillandIntangibleAssets	60200000	USD
CY2016Q4	smg	Disposal Group Including Discontinued Operation Other Income Expense Net DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet	100000	USD
CY2017Q4	smg	Disposal Group Including Discontinued Operation Other Income Expense Net DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpenseNet	0	USD
CY2016Q4	smg	Gain Loss On Sale Of Long Lived Assets GainLossOnSaleOfLongLivedAssets	-100000	USD
CY2017Q4	smg	Gain Loss On Sale Of Long Lived Assets GainLossOnSaleOfLongLivedAssets	200000	USD
CY2016Q4	smg	Impairment Restructuring And Other Recoveries Charges Continuing Operations ImpairmentRestructuringAndOtherRecoveriesChargesContinuingOperations	-200000	USD
CY2017Q4	smg	Impairment Restructuring And Other Recoveries Charges Continuing Operations ImpairmentRestructuringAndOtherRecoveriesChargesContinuingOperations	-200000	USD
CY2016Q4	smg	Intercompany Assets IntercompanyAssets	0	USD
CY2017Q3	smg	Intercompany Assets IntercompanyAssets	0	USD
CY2017Q4	smg	Intercompany Assets IntercompanyAssets	0	USD
CY2016Q4	smg	Intercompany Liabilities IntercompanyLiabilities	0	USD
CY2017Q3	smg	Intercompany Liabilities IntercompanyLiabilities	0	USD
CY2017Q4	smg	Intercompany Liabilities IntercompanyLiabilities	0	USD
CY2017Q4	smg	Interest Coverage Ratio InterestCoverageRatio	7.32
CY2017Q4	smg	Leverage Ratio LeverageRatio	3.11
CY2017Q4	smg	Leverage Ratio Restricted Payment Threshold LeverageRatioRestrictedPaymentThreshold	4.00
CY2017Q4	smg	Payments For Proceeds From Intercompany Advances From Financing Activities PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities	0	USD
CY2017Q4	smg	Payments For Restructuring And Other PaymentsForRestructuringAndOther	4000000	USD
CY2016Q4	smg	Payments Of Proceeds From Distributions To Fromaffiliates PaymentsOfProceedsFromDistributionsToFromaffiliates	100000	USD
CY2017Q4	smg	Payments Of Proceeds From Distributions To Fromaffiliates PaymentsOfProceedsFromDistributionsToFromaffiliates	0	USD
	smg	Percentage Of Annual Net Sales PercentageOfAnnualNetSales	0.75
	smg	Percentage Of Annual Net Sales PercentageOfAnnualNetSales	0.75
CY2017Q4	smg	Percentage Of Annual Net Sales PercentageOfAnnualNetSales	0.75
CY2017Q4	smg	Restructuring And Other Related Charges Continuing Operations RestructuringAndOtherRelatedChargesContinuingOperations	-200000	USD
CY2016Q4	smg	Restructuring And Other Related Charges Discontinued Operations RestructuringAndOtherRelatedChargesDiscontinuedOperations	2200000	USD
CY2017Q4	smg	Restructuring And Other Related Charges Discontinued Operations RestructuringAndOtherRelatedChargesDiscontinuedOperations	1400000	USD
CY2017Q4	smg	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit	45900000	USD
CY2017Q4	smg	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	14000000	USD
CY2016Q4	smg	Total Impairment Restructuring And Other Charges TotalImpairmentRestructuringAndOtherCharges	2000000	USD
CY2017Q4	smg	Total Impairment Restructuring And Other Charges TotalImpairmentRestructuringAndOtherCharges	1200000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	218400000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	153100000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	223200000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	175700000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	197700000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	128400000	USD
CY2017Q4	us-gaap	Accrual For Environmental Loss Contingencies Gross AccrualForEnvironmentalLossContingenciesGross	4300000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	562900000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	591100000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	602000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-117100000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-69200000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-68200000	USD
CY2016Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6100000	USD
CY2017Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7100000	USD
CY2016Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3200000	USD
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6000000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3800000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3100000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2300000	USD
CY2016Q4	us-gaap	Assets Assets	3012200000	USD
CY2017Q3	us-gaap	Assets Assets	2747000000	USD
CY2017Q4	us-gaap	Assets Assets	2910800000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	1241200000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	881700000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	982900000	USD
CY2016Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	245900000	USD
CY2017Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2017Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2016Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	245900000	USD
CY2017Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2017Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2016Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2700000	USD
CY2017Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1300000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28600000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73100000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120500000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54500000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	50100000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	88700000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	120500000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	54500000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	38600000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-66000000	USD
CY2016Q4	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-2600000	USD
CY2017Q4	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2016Q4	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-29300000	USD
CY2017Q4	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1400000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.5
CY2017Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.53
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59900000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58100000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57200000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59900000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58100000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57200000	shares
CY2016Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	402400000	USD
CY2017Q3	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	407600000	USD
CY2017Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	407900000	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-65100000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-20200000	USD
CY2016Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	170600000	USD
CY2017Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	187500000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1699100000	USD
CY2017Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1409700000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1791300000	USD
CY2017Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2016Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.043
CY2017Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.047
CY2016Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2100000	USD
CY2017Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-47600000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	157500000	USD
CY2016Q4	us-gaap	Depreciation Depreciation	14000000	USD
CY2017Q4	us-gaap	Depreciation Depreciation	12700000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	2500000	USD
CY2017Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	5700000	USD
CY2017Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	300000	USD
CY2016Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-10300000	USD
CY2017Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-1200000	USD
CY2016Q4	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-3500000	USD
CY2017Q4	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	53700000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	37300000	USD
CY2016Q3	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	21500000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	15600000	USD
CY2017Q3	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Interest Expense DisposalGroupIncludingDiscontinuedOperationInterestExpense	300000	USD
CY2017Q4	us-gaap	Disposal Group Including Discontinued Operation Interest Expense DisposalGroupIncludingDiscontinuedOperationInterestExpense	0	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Inventory Current DisposalGroupIncludingDiscontinuedOperationInventoryCurrent	70400000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-47000000	USD
CY2017Q4	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	0	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	52700000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	15000000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Liabilities DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities	18600000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	7000000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent	24000000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	39400000	USD
CY2017Q4	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	0	USD
CY2016Q4	us-gaap	Dividends Dividends	30100000	USD
CY2017Q4	us-gaap	Dividends Dividends	31100000	USD
CY2016Q4	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	0	USD
CY2017Q3	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	21900000	USD
CY2017Q4	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	21900000	USD
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.09
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.09
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2016Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2800000	USD
CY2017Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	600000	USD
CY2016Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.357
CY2017Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.769
CY2016Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	900000	USD
CY2017Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2300000	USD
CY2016Q4	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2017Q4	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2016Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	0	USD
CY2017Q3	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	0	USD
CY2017Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	0	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	83900000	USD
CY2017Q3	us-gaap	Equity Method Investments EquityMethodInvestments	31100000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	31700000	USD
CY2016Q4	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	800000	USD
CY2017Q4	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2016Q4	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-300000	USD
CY2017Q4	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	200000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	397400000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	441600000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	464800000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	36800000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	34000000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-58100000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-20000000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-90300000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86600000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-58100000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-20000000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.97
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.35
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.97
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.35
CY2016Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-6800000	USD
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1200000	USD
CY2016Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.12
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.02
CY2016Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.12
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.02
CY2016Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-13200000	USD
CY2017Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	600000	USD
CY2016Q4	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-15400000	USD
CY2017Q4	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	600000	USD
CY2016Q4	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2017Q4	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-32200000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-66600000	USD
CY2017Q4	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	100000	USD
CY2017Q4	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	10700000	USD
CY2016Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	900000	USD
CY2017Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1500000	USD
CY2016Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	100800000	USD
CY2017Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	84000000	USD
CY2016Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-139600000	USD
CY2017Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-117600000	USD
CY2016Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	308300000	USD
CY2017Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	282700000	USD
CY2016Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-104800000	USD
CY2017Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-83300000	USD
CY2016Q4	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-2200000	USD
CY2017Q4	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	5200000	USD
CY2016Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1100000	USD
CY2017Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	400000	USD
CY2016Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1400000	USD
CY2017Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6300000	USD
CY2016Q4	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-11600000	USD
CY2017Q4	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-2800000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	734000000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	748900000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	783400000	USD
CY2016Q4	us-gaap	Interest Expense InterestExpense	15300000	USD
CY2017Q4	us-gaap	Interest Expense InterestExpense	17800000	USD
CY2016Q4	us-gaap	Interest Income Other InterestIncomeOther	2700000	USD
CY2017Q4	us-gaap	Interest Income Other InterestIncomeOther	2500000	USD
CY2016Q4	us-gaap	Interest Paid Net InterestPaidNet	17300000	USD
CY2017Q4	us-gaap	Interest Paid Net InterestPaidNet	25500000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	461900000	USD
CY2017Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	210600000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	462300000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	685900000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	407500000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	696100000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	163100000	USD
CY2017Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	139300000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	162800000	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	7200000	USD
CY2017Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10500000	USD
CY2017Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	11400000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	60900000	USD
CY2017Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	57600000	USD
CY2017Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	71000000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2017Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2016Q4	us-gaap	Liabilities Liabilities	2420000000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	2085300000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	2403000000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3012200000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2747000000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2910800000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	490600000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	544500000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	471100000	USD
CY2016Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	137700000	USD
CY2016Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	137700000	USD
CY2017Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2017Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2015Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1900000000.0	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	41800000	USD
CY2017Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	143100000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	86100000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1648100000	USD
CY2017Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1258000000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1697000000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	12400000	USD
CY2017Q3	us-gaap	Minority Interest MinorityInterest	12900000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	5000000	USD
CY2016Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8100000	USD
CY2017Q4	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	7900000	USD
CY2017Q4	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	13600000	USD
CY2016Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	345200000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	308700000	USD
CY2016Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94000000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-164800000	USD
CY2016Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-209800000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-210500000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-65300000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-21200000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	400000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q4	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	0	USD
CY2017Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-61800000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-71900000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	117700000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176000000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	183900000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-4000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	3400000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	700000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-200000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-200000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-400000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-300000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Reclassification Adjustments Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax	300000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Reclassification Adjustments Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax	200000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-400000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	100000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	200000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	-100000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	400000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	300000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	3000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	800000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	1900000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	500000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	92700000	USD
CY2017Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	248300000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	161800000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	281300000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	260900000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	213000000	USD
CY2016Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2017Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2500000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2016Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	5300000	USD
CY2017Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2100000	USD
CY2016Q4	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	0	USD
CY2017Q4	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	0	USD
CY2016Q4	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	0	USD
CY2017Q4	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	5300000	USD
CY2016Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	43600000	USD
CY2017Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	96200000	USD
CY2016Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	30000000	USD
CY2017Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	30500000	USD
CY2016Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3500000	USD
CY2017Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2016Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2017Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	100000	USD
CY2016Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	77900000	USD
CY2017Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	140100000	USD
CY2016Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16100000	USD
CY2017Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19400000	USD
CY2016Q4	us-gaap	Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue	0	USD
CY2017Q3	us-gaap	Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue	88900000	USD
CY2017Q4	us-gaap	Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue	42200000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	60600000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	67100000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61700000	USD
CY2017Q4	us-gaap	Proceeds And Excess Tax Benefit From Sharebased Compensation ProceedsAndExcessTaxBenefitFromSharebasedCompensation	400000	USD
CY2016Q4	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	250000000	USD
CY2017Q4	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2016Q4	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	459000000	USD
CY2017Q4	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	573400000	USD
CY2016Q4	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	100000	USD
CY2017Q4	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1300000	USD
CY2017Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	-64900000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	-21200000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	438000000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	467700000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	464100000	USD
CY2016Q4	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	282300000	USD
CY2017Q4	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	136000000	USD
CY2016Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6500000	USD
CY2017Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3000000	USD
CY2017Q3	us-gaap	Restructuring Reserve RestructuringReserve	12100000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	9300000	USD
CY2017Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	1500000	USD
CY2016Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	-200000	USD
CY2017Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	-200000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	786400000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	978200000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	925900000	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	207400000	USD
CY2017Q4	us-gaap	Sales Revenue Net SalesRevenueNet	221500000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	104100000	USD
CY2017Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	108200000	USD
CY2016Q4	us-gaap	Share Based Compensation ShareBasedCompensation	2300000	USD
CY2017Q4	us-gaap	Share Based Compensation ShareBasedCompensation	6000000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3996.000000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	210065.000000	shares
CY2016Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	300000	USD
CY2017Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	20600000	USD
CY2016Q4	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	1400000	USD
CY2017Q4	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	1600000	USD
CY2014Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000.0	USD
CY2016Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1000000000	USD
CY2014Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P5Y
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5700000	shares
CY2017Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1000000.0	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	488100000	USD
CY2017Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	96600000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	579800000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	648800000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	502800000	USD
CY2016Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	734300000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	592200000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	661700000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	507800000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	8300000	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	10000000	shares
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	10900000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	491900000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	667800000	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	762800000	USD
CY2016Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	43400000	USD
CY2017Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	96600000	USD
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	9200000	USD
CY2017Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8600000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8200000	USD
CY2017Q4	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	3200000	USD
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60100000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57600000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60100000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57600000	shares
CY2017Q4	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONTINGENCIES</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. </font></div><div style="line-height:120%;padding-top:10px;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Regulatory Matters</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;"> was accrued in the “Other liabilities” line in the Condensed Consolidated Balance Sheets for environmental actions, the majority of which are for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. It is not currently possible to reasonably estimate a probable loss, if any, associated with these cases and, accordingly, no accruals have been recorded in the Company’s condensed consolidated financial statements. The Company is reviewing agreements and policies that may provide insurance coverage or indemnity as to these claims and is pursuing coverage under some of these agreements and policies, although there can be no assurance of the results of these efforts. There can be no assurance that these cases, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, the Company, along with its Chief Executive Officer, have been named as defendants in four actions filed on and after June 27, 2012, which have been consolidated, and, on March 31, 2017, certified as a class action in the United States District Court for the Southern District of California as </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Morning Song Bird Food Litigation</font><font style="font-family:inherit;font-size:10pt;">, Lead Case No. 3:12-cv-01592-JAH-AGS. The plaintiffs allege various statutory and common law claims associated with the Company’s sale of wild bird food products and a plea agreement entered into in previously pending government proceedings associated with such sales. The plaintiffs allege, among other things, a class action on behalf of all persons and entities in the United States who purchased certain bird food products. The plaintiffs assert: (i) hundreds of millions of dollars in monetary damages (actual, compensatory, consequential, and restitution); (ii) punitive and treble damages; (iii) injunctive and declaratory relief; (iv) pre-judgment and post-judgment interest; and (v) costs and attorneys’ fees. The Company and its Chief Executive Officer dispute the plaintiffs’ assertions and intend to vigorously defend the consolidated action. At this point in the proceedings, it is not currently possible to reasonably estimate a probable loss, if any, associated with the action and, accordingly, no accruals have been recorded in the consolidated financial statements with respect to the action. There can be no assurance that this action, whether as a result of an adverse outcome or as a result of significant defense costs, will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been named as a defendant in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Scotts EZ Seed Litigation</font><font style="font-family:inherit;font-size:10pt;">, Case No. 12-cv-4727 (VB), a New York and California class action lawsuit filed August 9, 2012 in the United States District Court for the Southern District of New York that asserts claims under false advertising and other legal theories based on a marketing statement on the Company’s EZ Seed grass seed product from 2009 to 2012. The plaintiffs seek, on behalf of themselves and purported class members, various forms of monetary and non-monetary relief, including statutory damages that they contend could amount to hundreds of millions of dollars. The Company has defended the action vigorously, disputes the plaintiffs’ claims and theories, including the recoverability of statutory damages, and intends to continue vigorously defending the action. In 2017, the Court eliminated certain claims, narrowed the case in certain respects, and permitted the case to continue proceeding as a class action. On August 7, 2017, the Court requested briefs on the Company’s request for interlocutory review of issues relating to the recoverability of statutory damages in a class action by the United States Court of Appeals for the Second Circuit and, on August 31, 2017, approved that request. On January 8, 2018, however, the Second Circuit denied the interlocutory appeal request. At this point in the proceedings, it is not currently possible to reasonably estimate a probable loss, if any, associated with the action and, accordingly, no accruals have been recorded in our consolidated financial statements with respect to the action. There can be no assurance that this action will not have a material adverse effect on our financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.</font></div></div>
CY2017Q4	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001546380-18-000005-index-headers.html	Edgar Link	pending
0001546380-18-000005-index.html	Edgar Link	pending
0001546380-18-000005.txt	Edgar Link	pending
0001546380-18-000005-xbrl.zip	Edgar Link	pending
exhibit101smg12302017q1f18.htm	Edgar Link	pending
exhibit21smg12302017q1f18.htm	Edgar Link	pending
exhibit311smg12302017q1f18.htm	Edgar Link	pending
exhibit312smg12302017q1f18.htm	Edgar Link	pending
exhibit32smg12302017q1f18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
smg-1230201710xq1.htm	Edgar Link	pending
smg-20171230.xml	Edgar Link	completed
smg-20171230.xsd	Edgar Link	pending
smg-20171230_cal.xml	Edgar Link	unprocessable
smg-20171230_def.xml	Edgar Link	unprocessable
smg-20171230_lab.xml	Edgar Link	unprocessable
smg-20171230_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SMG
SCOTTS MIRACLE-GRO CO Stock $smg

2017 Q4 Form 10-Q Financial Statement

#000154638018000005 Filed on February 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SMG SCOTTS MIRACLE-GRO CO Stock $smg

2017 Q4 Form 10-Q Financial Statement

#000154638018000005 Filed on February 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SMG
SCOTTS MIRACLE-GRO CO Stock $smg